封面
市場調查報告書
商品編碼
1417529

乳房病變定位市場報告:至2030年的趨勢、預測與競爭分析

Breast Lesion Localization Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

乳房病變定位的趨勢和預測

預計到2030年,全球乳房病變定位市場將達到約 4.53 億美元,2024年至2030年年複合成長率為 7.1%。該市場的主要驅動力是乳癌早期檢測知識的增加、乳癌手術數量的增加以及對精準微創手術的需求不斷成長。全球乳房病變定位市場的未來前景廣闊,醫院和診所、診斷影像中心和門診手術中心市場充滿機會。

乳房病變定位市場洞察

Lucintel 預測,由於早期乳癌檢出率的增加以及向侵入性較小的方法的轉變,保乳治療預計將在預測期內出現強勁成長。

由於醫院數量增加、醫療保健支出增加、患者數量大幅增加以及醫療保健服務需求不斷成長,預計亞太地區將在預測期內實現最高成長。

常問問題

Q1.市場規模有多大?

A1.到2030年,全球乳房局部定位市場預計將達到 4.53 億美元。

Q2.市場成長預測如何?

A2.預計2024年至2030年,全球乳房病變局部市場將以 7.1%的年複合成長率成長。

Q3.影響市場成長的主要促進因素有哪些?

A3.該市場的主要驅動力是乳癌早期檢測知識的增加、乳癌手術數量的增加以及對精準微創手術的需求不斷成長。

Q4.市場的主要細分市場是什麼?

A4.全球乳房病變定位市場的未來充滿希望,醫院和診所、診斷影像中心和門診手術中心市場都有機會。

Q5.市場上主要企業有哪些?

A5.乳房病灶定位的主要企業如下。

  • GE Healthcare
  • Dragerwerk
  • Koninklijke Philips
  • Ambu AS
  • Medline Industrie

Q6.未來最大的細分市場是什麼?

A6.Lucintel 預測,由於早期乳癌檢出率的增加以及向侵入性較小的方法的轉變,乳房保護將在預測期內出現強勁成長。

Q7.未來五年預計哪個地區將成為最大的市場?

A7.由於醫院數量不斷增加、醫療保健支出不斷增加、患者數量和醫療保健服務需求顯著增加,預計亞太地區在預測期內將呈現最高成長。

Q8.可以客製化報告嗎?

A8.是的,Lucintel 提供 10%的客製化服務,無需額外付費。

目錄

第1章 執行摘要

第2章 全球乳房病變定位市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球乳房病變定位市場趨勢(2018-2023)與預測(2024-2030)
  • 依類型分類的全球乳房病變定位市場
    • 金屬線定位
    • 放射性同位素定位
    • 磁定位
    • 電磁定位
    • 其他
  • 全球乳房病變定位市場(依應用)
    • 乳房切片
    • 乳房保護
  • 依最終用途分類的全球乳房病變定位市場
    • 醫院和診所
    • 影像診斷中心
    • 門診手術中心
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球乳房病變定位市場(依地區)
  • 北美乳房病變定位市場
  • 歐洲乳房病變定位市場
  • 亞太地區乳房病變定位市場
  • 其他地區乳房病變定位市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球乳房病變定位市場成長機會(依類型)
    • 全球乳房病變定位市場成長機會(依應用)
    • 全球乳房病變定位市場成長機會(依最終用途)
    • 全球乳房病變定位市場成長機會(依地區)
  • 全球乳房病變定位市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球乳房病變定位市場的產能擴張
    • 全球乳房病變定位市場的併購和合資企業
    • 認證和許可

第7章 主要企業概況

  • GE Healthcare
  • Dragerwerk
  • Koninklijke Philips
  • Ambu AS
  • Medline Industrie
簡介目錄

Breast Lesion Localization Trends and Forecast

The future of the global breast lesion localization market looks promising with opportunities in the hospital & clinic, diagnostic imaging center, and ambulatory surgical center markets. The global breast lesion localization market is expected to reach an estimated $453 million by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increased knowledge of early breast cancer detection, rise in the number of breast cancer surgeries, as well as, growing need for accurate and minimally invasive surgeries.

A more than 150-page report is developed to help in your business decisions.

Breast Lesion Localization by Segment

The study includes a forecast for the global breast lesion localization by type, usage, end use, and region.

Breast Lesion Localization Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Wire Localization
  • Radioisotope Localization
  • Magnetic Localization
  • Electromagnetic Localization
  • Others

Breast Lesion Localization Market by Usage [Shipment Analysis by Value from 2018 to 2030]:

  • Breast Biopsy
  • Breast Conservation

Breast Lesion Localization Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Others

Breast Lesion Localization Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Breast Lesion Localization Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies breast lesion localization companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the breast lesion localization companies profiled in this report include-

  • GE Healthcare
  • Dragerwerk
  • Koninklijke Philips
  • Ambu AS
  • Medline Industrie

Breast Lesion Localization Market Insights

Lucintel forecasts that breast conservation is expected to witness the higher growth over the forecast period due to the increased detection of early-stage breast cancer and the trend toward less invasive methods.

APAC is expected to witness highest growth over the forecast period due to growing number of hospitals and rising healthcare expenditure, a large increase in patient volume, and a need for healthcare services.

Features of the Global Breast Lesion Localization Market

Market Size Estimates: Breast lesion localization market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Breast lesion localization market size by type, usage, end use, and region in terms of value ($M).

Regional Analysis: Breast lesion localization market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, usage, end use, and regions for the breast lesion localization market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the breast lesion localization market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the breast lesion localization market size?

Answer: The global breast lesion localization market is expected to reach an estimated $453 million by 2030.

Q2. What is the growth forecast for breast lesion localization market?

Answer: The global breast lesion localization market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the breast lesion localization market?

Answer: The major drivers for this market are increased knowledge of early breast cancer detection, rise in the number of breast cancer surgeries, as well as, growing need for accurate and minimally invasive surgeries.

Q4. What are the major segments for breast lesion localization market?

Answer: The future of the global breast lesion localization market looks promising with opportunities in the hospital & clinic, diagnostic imaging center, and ambulatory surgical center markets.

Q5. Who are the key breast lesion localization market companies?

Answer: Some of the key breast lesion localization companies are as follows.

  • GE Healthcare
  • Dragerwerk
  • Koninklijke Philips
  • Ambu AS
  • Medline Industrie

Q6. Which breast lesion localization market segment will be the largest in future?

Answer: Lucintel forecasts that breast conservation is expected to witness the higher growth over the forecast period due to the increased detection of early-stage breast cancer and the trend toward less invasive methods.

Q7. In breast lesion localization market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing number of hospitals and rising healthcare expenditure, a large increase in patient volume, and a need for healthcare services.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the breast lesion localization market by type (wire localization, radioisotope localization, magnetic localization, electromagnetic localization, and others), usage (breast biopsy and breast conservation), end use (hospitals & clinics, diagnostic imaging centers, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Breast Lesion Localization Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Breast Lesion Localization Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Breast Lesion Localization Market by Type
    • 3.3.1: Wire Localization
    • 3.3.2: Radioisotope Localization
    • 3.3.3: Magnetic Localization
    • 3.3.4: Electromagnetic Localization
    • 3.3.5: Others
  • 3.4: Global Breast Lesion Localization Market by Usage
    • 3.4.1: Breast Biopsy
    • 3.4.2: Breast Conservation
  • 3.5: Global Breast Lesion Localization Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Diagnostic Imaging Centers
    • 3.5.3: Ambulatory Surgical Centers
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Breast Lesion Localization Market by Region
  • 4.2: North American Breast Lesion Localization Market
    • 4.2.1: North American Breast Lesion Localization Market by Usage: Breast Biopsy and Breast Conservation
    • 4.2.2: North American Breast Lesion Localization Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others
  • 4.3: European Breast Lesion Localization Market
    • 4.3.1: European Breast Lesion Localization Market by Usage: Breast Biopsy and Breast Conservation
    • 4.3.2: European Breast Lesion Localization Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Breast Lesion Localization Market
    • 4.4.1: APAC Breast Lesion Localization Market by Usage: Breast Biopsy and Breast Conservation
    • 4.4.2: APAC Breast Lesion Localization Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Breast Lesion Localization Market
    • 4.5.1: ROW Breast Lesion Localization Market by Usage: Breast Biopsy and Breast Conservation
    • 4.5.2: ROW Breast Lesion Localization Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Breast Lesion Localization Market by Type
    • 6.1.2: Growth Opportunities for the Global Breast Lesion Localization Market by Usage
    • 6.1.3: Growth Opportunities for the Global Breast Lesion Localization Market by End Use
    • 6.1.4: Growth Opportunities for the Global Breast Lesion Localization Market by Region
  • 6.2: Emerging Trends in the Global Breast Lesion Localization Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Breast Lesion Localization Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Breast Lesion Localization Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GE Healthcare
  • 7.2: Dragerwerk
  • 7.3: Koninklijke Philips
  • 7.4: Ambu AS
  • 7.5: Medline Industrie